Kåre Schultz, Teva CEO (Christopher Goodney/Bloomberg via Getty Images)

Te­va reach­es $100M set­tle­ment with Rhode Is­land for decade of an­ti-nar­cot­ic drugs and $21M cash

Kåre Schultz, the top dog at Te­va Phar­ma­ceu­ti­cals, said last month on a Q4 call that the phar­ma gi­ant was con­fi­dent it could reach a …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.